Endocannabinoid Activity Remodulation for Psychosis Liability in Youth

Conditions:   Clinical High Risk for Psychosis;   Ultra High Risk for Psychosis;   Attenuated Psychotic Symptoms Intervention:   Dietary Supplement: Ultra-micronized Palmitoylethanolamide (PEA) Sponsors:   University of Udine;   National Research Council (CNR), Institute of Biomolecular Chemistry (ICB), Italy Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials